Michael Morrissey
Förmögenhet: 171 M $ per 2026-05-31
Förmögenhet: 171 M $ per 2026-05-31
Michael M.
Morrissey is President, Chief Executive Officer & Director at Exelixis, Inc. since 2010 and has been with the company since 2000.
Dr. Morrissey is Chairman at Vera Therapeutics, Inc. since 2022.
Formerly, Dr. Morrissey was Director at XWPharma Ltd. from 2020 to 2023, Director at CERo Therapeutics, Inc. in 2022, Senior Scientist at Ciba-Geigy Corp.
from 1986 to 1991, and Vice President-Discovery Research at Berlex Biosciences from 1991 to 2000.
Dr. Morrissey earned a doctorate from Harvard University and completed undergraduate studies at the University of Wisconsin.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
EXELIXIS, INC. 1,35 % | 2026-05-18 | 3 384 063 ( 1,35 % ) | 171 M $ | 2026-05-31 |
| 2026-05-21 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| EXELIXIS, INC. | Verkställande Direktör | 2010-07-22 |
| VERA THERAPEUTICS, INC. | Ordförande | 2022-05-24 |
| Företag | Position | Slut |
|---|---|---|
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Develops drug products for neurological disorders | Direktör/Styrelseledamot | 2023-04-01 |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Direktör/Styrelseledamot | 2022-11-01 |
Berlex Biosciences | Företagsledare/Principal | 2000-01-01 |
Ciba-Geigy Corp.
Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Teknisk/Vetenskaplig/F&U Direktör | 1991-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Ciba-Geigy Corp.
Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Develops drug products for neurological disorders | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Health Technology |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån